0.35 (8.43%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Strong
Earnings
Strong
Earnings
Very Strong
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Strong
Website
CAMP4 Therapeutics Corporation
Telephone
1.617.651.8867
Address
3rd floor, Building 1400 West, 1 Kendall Square, Cambridge, MA 02139
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.3 - 7.75
Trade Value (12mth)
US$277,757.00
1 week
-3.71%
1 month
-10.17%
YTD
-30.83%
1 year
109.6%
All time high
12.30
EPS 3 yr Growth
16.80%
EBITDA Margin
NaN%
Operating Cashflow
-$30m
Free Cash Flow Return
-50.00%
ROIC
-136.20%
Interest Coverage
0.00
Quick Ratio
7.40
Shares Outstanding (Fully Diluted)
58m
HALO Sector
Healthcare
Next Company Report Date
01-Apr-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 14 May 26 | |
| 14 May 26 | |
| 14 May 26 | |
| 08 May 26 | |
| 08 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -2.53 | -2.57 | -2.65 | | | | ||
EPS (Fully Diluted) | $ | | | | | -2.53 | -2.57 | -2.65 | | | | ||
Growth | % | | | | | -11.5 | -1.7 | -2.9 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
